Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-06-01 @ 9:53 AM
Study NCT ID:
NCT00003969
Status:
COMPLETED
Last Update Posted:
2013-06-26
First Post:
1999-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Geldanamycin Analogue in Treating Patients With Advanced Cancer
Sponsor:
Cancer Research UK
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CRC-PHASE-I-PH1/074
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None